X4 Pharmaceuticals announces $145.6 million public offering of common stock
PositiveFinancial Markets

X4 Pharmaceuticals has announced a significant public offering of common stock, raising $145.6 million. This move is crucial for the company as it aims to bolster its financial position and fund ongoing research and development efforts. Such capital can enhance their ability to innovate and bring new therapies to market, which is vital for patients and investors alike.
— Curated by the World Pulse Now AI Editorial System







